Duff & Phelps Investment Management Co. raised its stake in shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 7.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,183,719 shares of the real estate investment trust's stock after purchasing an additional 156,309 shares during the period. Duff & Phelps Investment Management Co. owned 0.92% of Sabra Health Care REIT worth $40,639,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. raised its holdings in Sabra Health Care REIT by 4.5% during the 3rd quarter. Rockefeller Capital Management L.P. now owns 15,369 shares of the real estate investment trust's stock valued at $286,000 after buying an additional 655 shares during the period. GAMMA Investing LLC increased its position in Sabra Health Care REIT by 25.3% during the third quarter. GAMMA Investing LLC now owns 4,614 shares of the real estate investment trust's stock valued at $86,000 after acquiring an additional 932 shares during the last quarter. Mercer Global Advisors Inc. ADV raised its stake in shares of Sabra Health Care REIT by 2.5% in the second quarter. Mercer Global Advisors Inc. ADV now owns 48,448 shares of the real estate investment trust's stock valued at $746,000 after acquiring an additional 1,168 shares during the period. Assetmark Inc. lifted its holdings in shares of Sabra Health Care REIT by 168.4% in the 3rd quarter. Assetmark Inc. now owns 1,962 shares of the real estate investment trust's stock worth $37,000 after acquiring an additional 1,231 shares during the last quarter. Finally, Arizona State Retirement System boosted its stake in shares of Sabra Health Care REIT by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 64,802 shares of the real estate investment trust's stock worth $998,000 after purchasing an additional 1,258 shares during the period. 99.40% of the stock is currently owned by hedge funds and other institutional investors.
Sabra Health Care REIT Stock Down 1.4 %
SBRA traded down $0.25 on Monday, hitting $17.79. The company had a trading volume of 2,198,113 shares, compared to its average volume of 2,038,393. The stock has a market capitalization of $4.21 billion, a price-to-earnings ratio of 43.39, a P/E/G ratio of 2.26 and a beta of 1.24. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16. The stock has a fifty day moving average price of $18.60 and a 200-day moving average price of $16.99. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03.
Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The firm had revenue of $178.00 million during the quarter, compared to analysts' expectations of $177.19 million. Sabra Health Care REIT had a return on equity of 3.51% and a net margin of 14.20%. During the same period in the previous year, the firm earned $0.34 EPS. Analysts predict that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 29th. Investors of record on Friday, November 15th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, November 15th. This represents a $1.20 annualized dividend and a yield of 6.75%. Sabra Health Care REIT's dividend payout ratio (DPR) is 292.69%.
Analyst Ratings Changes
SBRA has been the subject of several analyst reports. Wells Fargo & Company raised shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $16.00 to $20.00 in a research note on Tuesday, October 1st. Scotiabank raised their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Truist Financial upped their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a research report on Wednesday, September 4th. Citigroup upgraded Sabra Health Care REIT from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Mizuho restated a "neutral" rating and issued a $20.00 price target on shares of Sabra Health Care REIT in a report on Thursday. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $19.14.
Check Out Our Latest Report on Sabra Health Care REIT
About Sabra Health Care REIT
(
Free Report)
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.
Featured Stories
Before you consider Sabra Health Care REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.
While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.